Entresto is the first new drug in decades for helping patients whose lives are in danger because their hearts cannot pump blood efficiently. Analysts estimate it could have annual sales of some $5.4 billion by 2020.

 

(Reporting by Joshua Franklin; Editing by Maria Sheahan)

Source: Reuters Health

http://www.reuters.com/article/2015/11/24/us-novartis-drugs-approval-idUSKBN0TD0DP20151124